P556: CHANGES IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA RECEIVING IVOSIDENIB + AZACITIDINE OR PLACEBO + AZACITIDINE

Autor: A. Schuh, S. de Botton, C. Recher, S. Vives Polo, E. Zarzycka, J. Wang, G. Bertani, M. Heuser, R. Calado, S.-P. Yeh, J. Hui, S. Pandya, D. Gianolio, C. Chamberlain, H. Dohner, P. Montesinos

Publikováno v: HemaSphere, Vol 6, Pp 455-456 (2022)

Externí odkaz: https://doaj.org/article/1d19f77e4e27470cb46d77eef9808da0

P557: HEMATOLOGIC IMPROVEMENTS WITH IVOSIDENIB + AZACITIDINE COMPARED WITH PLACEBO + AZACITIDINE IN PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA

Autor: H. Dohner, P. Montesinos, S. Vives Polo, E. Zarzycka, J. Wang, G. Bertani, M. Heuser, R. Calado, A. Schuh, S.-P. Yeh, A. de la Fuente, C. Cerchione, S. Daigle, J. Hui, S. Pandya, D. Gianolio, C. Recher, S. de Botton

Publikováno v: HemaSphere, Vol 6, Pp 456-457 (2022)

Externí odkaz: https://doaj.org/article/faf421a3f0c948139ad57d2058d5e94e

PB1805: INSIGHTS FROM ORAL AZACITIDINE EARLY ACCESS PROGRAM IN FRANCE: PATIENT POPULATION WITH ACUTE MYELOID LEUKEMIA RECEIVING ORAL-AZA FOR MAINTENANCE OF COMPLETE REMISSION AFTER INDUCTION CHEMOTHERAPY

Autor: E. Raffoux, S. De Botton, L. Ades, M. Carré, T. Cluzeau, C. Saillard, M. Heiblig, F. Beckerich, L. Gastaud, A. Dupuis, U. Richez, P.-Y. Dumas

Publikováno v: HemaSphere, Vol 6, Pp 1685-1686 (2022)

Externí odkaz: https://doaj.org/article/78a7658c9c93494b944951e20cbcdec0

Effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study

Autor: Claude Preudhomme, Cyril Quivoron, Sophie Broutin, Emmanuelle Clappier, Aline Renneville, S. de Botton, Christophe Willekens, Angelo Paci, Ramy Rahmé, Julien Rossignol, Pierre Fenaux, Laurence Simon, Raphael Itzykson, Alice Marceau, Eyal C. Attar, Véronique Saada, Mark G. Frattini, Jean-Baptiste Micol, Madalina Uzunov, Florence Pasquier, Laurent Pascal, Thorsten Braun, Emmanuel Raffoux, Matthieu Duchmann, Julia Delahousse, V. Vidal, Virginie Penard-Lacronique, Lionel Adès

Publikováno v: Leukemia & Lymphoma. 62:438-445

Isocitrate dehydrogenase 1 (IDH1) and 2 (IDH2) mutations in Myeloid Neoplams (MNs) exhibit DNA hypermethylation via 2-hydroxyglutarate (2HG) over-production. Clinical impact of azacitidine (AZA) re...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a65c07afb412d7e56db2291d190188a1
https://doi.org/10.1080/10428194.2020.1832661

Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights

Autor: Sylvain Garciaz, Olivier Caron, Amine Belhabri, Norbert Vey, Jacques Vargaftig, Veronique Verge, Sophie Cotteret, S. de Botton, Flore Salviat, Suzette Delaloge, Iléana Antony-Debré, Patricia Pautier, Christophe Marzac, Sarah Bertoli, Florence Pasquier, Jean-Baptiste Micol, Sabine Khalife-Hachem, Alexandra Leary, Etienne Rouleau, A Renneville, M Kfoury, Filippo Rosselli, Thomas Grinda, Christian Recher, Madalina Uzunov, Jean-Edouard Martin, Gabriel Etienne

Publikováno v: Annals of Oncology
Annals of Oncology, 2021, 32 (8), pp.1046-1048. ⟨10.1016/j.annonc.2021.04.015⟩
Annals of Oncology, Elsevier, 2021, 32 (8), pp.1046-1048. ⟨10.1016/j.annonc.2021.04.015⟩

International audience; No abstract available

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80d70c98b98dc8c66889f59574a78331
https://hal-amu.archives-ouvertes.fr/hal-03623367